Cytomed Therapeutics Limited (GDTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GDTC | AMGN | VRTX | REGN | GSK |
| Company | Cytomed Therapeutics Limited | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 2.0000 | 298.49 | 479.13 | 1,036.52 | 40.43 |
| High | 2.0300 | 303.97 | 479.15 | 1,049.50 | 40.68 |
| Low | 1.9900 | 296.56 | 473.11 | 1,026.01 | 40.36 |
| Last | 2.0300 | 303.28 | 473.69 | 1,045.37 | 40.66 |
| Change | +0.1300 | +4.66 | -7.04 | +8.85 | +0.01 |
| % Change | +6.99% | +1.56% | -1.46% | +0.85% | +0.02% |
| Volume | 1,800 | 1,875,900 | 1,190,200 | 446,100 | 2,131,400 |
| 20-Day Average Volume | 3,215 | 2,170,885 | 1,186,685 | 385,500 | 4,004,325 |
| Previous Close | 1.9000 | 298.62 | 480.73 | 1,036.52 | 40.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0500 | 304.72 | 465.02 | 998.05 | 42.76 |
| 20-Day Raw Stochastic | 39.09% | 37.34% | 74.96% | 95.75% | 5.52% |
| 20-Day Relative Strength | 47.74% | 53.85% | 64.36% | 71.10% | 39.24% |
| Weighted Alpha | -34.92 | +29.39 | +40.34 | +37.37 | +10.87 |
| Today's Opinion | 100% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.66% since 06/10/24 | -0.47% since 06/10/24 | -1.98% since 06/10/24 | +4.36% since 06/10/24 | -1.53% since 06/10/24 |
| Low | 1.9000 on 06/14/24 | 295.30 on 06/13/24 | 472.61 on 06/13/24 | 997.84 on 06/11/24 | 40.36 on 06/17/24 |
| High | 2.0800 on 06/14/24 | 303.97 on 06/17/24 | 483.53 on 06/14/24 | 1,049.50 on 06/17/24 | 41.38 on 06/12/24 |
| 1-Month | |||||
| %Chg | -4.11% since 05/17/24 | -2.94% since 05/17/24 | +6.40% since 05/17/24 | +6.42% since 05/17/24 | -9.60% since 05/17/24 |
| Low | 1.9000 on 06/14/24 | 295.30 on 06/13/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.36 on 06/17/24 |
| High | 2.1700 on 05/31/24 | 316.67 on 05/21/24 | 486.42 on 06/07/24 | 1,049.50 on 06/17/24 | 45.79 on 05/22/24 |
| 3-Month | |||||
| %Chg | -4.56% since 03/15/24 | +12.80% since 03/15/24 | +16.19% since 03/15/24 | +8.39% since 03/15/24 | -3.63% since 03/15/24 |
| Low | 1.9000 on 06/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 2.6100 on 03/20/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,049.50 on 06/17/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -39.32% since 12/15/23 | +10.10% since 12/15/23 | +15.34% since 12/15/23 | +21.68% since 12/15/23 | +13.32% since 12/15/23 |
| Low | 1.9000 on 06/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 838.46 on 12/21/23 | 36.18 on 12/20/23 |
| High | 5.5000 on 12/27/23 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,049.50 on 06/17/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,786 | 160,190,224 | 124,053,832 | 114,209,984 | 84,244,688 |
| Shares Outstanding, K | 10,940 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -3,130,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.63 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 07/22/24 | 08/01/24 | 08/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.03 | 31.92 | 27.93 | 10.06 |